246 related articles for article (PubMed ID: 8459875)
1. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
Lin CY; Lin CC; Huang TP
Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis.
Lin CY; Huang TP
Nephron; 1994; 68(4):437-41. PubMed ID: 7870228
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
Brauner A; Hylander B; Wretlind B
Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840
[TBL] [Abstract][Full Text] [Related]
4. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
[TBL] [Abstract][Full Text] [Related]
6. Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD).
KozioĊ-Montewka M; Ksiazek A; Janicka L; Baranowicz I
Inflamm Res; 1997 Apr; 46(4):132-6. PubMed ID: 9137991
[TBL] [Abstract][Full Text] [Related]
7. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis.
Lu Y; Hylander B; Brauner A
Perit Dial Int; 1996; 16(6):607-12. PubMed ID: 8981529
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 in chronic renal failure and dialysis patients.
Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
[TBL] [Abstract][Full Text] [Related]
10. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Nakahama H; Tanaka Y; Shirai D; Miyazaki M; Imai N; Yokokawa T; Okada M; Kubori S
Nephron; 1992; 61(2):132-4. PubMed ID: 1630534
[TBL] [Abstract][Full Text] [Related]
11. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
13. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
Lamperi S; Carozzi S
Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
[TBL] [Abstract][Full Text] [Related]
14. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
Brauner A; Hylander B; Wretlind B
Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis.
Betjes MG; Visser CE; Zemel D; Tuk CW; Struijk DG; Krediet RT; Arisz L; Beelen RH
Perit Dial Int; 1996; 16(4):385-92. PubMed ID: 8863332
[TBL] [Abstract][Full Text] [Related]
17. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
18. High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
Yang X; Tong Y; Yan H; Ni Z; Qian J; Fang W
Am J Nephrol; 2018; 47(5):317-324. PubMed ID: 29779030
[TBL] [Abstract][Full Text] [Related]
19. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
Lin CY; Huang TP
Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
[TBL] [Abstract][Full Text] [Related]
20. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG
Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
